It seems like U.S healthcare is more concerned about profits than patients these days. Now is the time to learn more about the latest legal battles patients face with conditions from head to toe and how to be your own best healthcare advocate, so you receive the care you deserve.
The U.S. Environmental Protection Agency (EPA) recently released an emergency order to suspend all registrations of the pesticide Dacthal (dimethyl tetrachloroterephthalate or DCPA) because of potentially serious health risks. This is the first time the agency has used its power to suspend the use of…
On February 2, 2024, the Judicial Panel on Multidistrict Litigation (JPML) ruled that all federal lawsuits involving Ozempic, Wegovy, Rybelsus, and similar medications be consolidated in the Eastern District of Pennsylvania for pre-trial proceedings. Since then, both sides have been working toward selecting a small…
The recent surge in popularity of Ozempic and other similar drugs—called GLP-1 inhibitors—has encouraged many people to take the medication for weight loss without incorporating recommended lifestyle changes like exercising and eating less. A recent study, however, warns against this approach. Scientists discovered that when…
On February 9, 2024, an Illinois woman filed a new Ozempic lawsuit in the U.S. District Court for the Northern District of Illinois. She claims that after taking the medication, she suffered from gastroparesis, also known as stomach paralysis. She seeks both compensatory and punitive…
On December 1, 2023, a group of plaintiffs filed a motion request with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all federally filed Ozempic, Wegovy, and Mounjaro lawsuits, alleging gastrointestinal and associated injuries. All of these products include medications called glucagon-like peptide-1…
The U.S. Food and Drug Administration (FDA) has been looking into the potential side effects of diabetes and weight-loss drugs Ozempic and Wegovy, including suicidal ideation. The administration noticed potential signals of the serious risk in the FDA Adverse Event Reporting System (FAERS), which contains…
In a significant development, the U.S. Food and Drug Administration (FDA) is poised to propose a ban on certain hair-straightening products, specifically those containing formaldehyde and other formaldehyde-releasing chemicals like methylene or glycol. These chemicals are common in various hair relaxers and pressing products and…
Two plaintiffs recently filed lawsuits against C.R. Bard and Becton, Dickinson and Company because they claim they were injured by allegedly defective PowerPort catheter devices. According to their complaints, these devices can crack and break, increasing the risk of serious infections and other complications. Given…
On October 7, 2022, the U.S. Judicial Panel on Multidistrict Litigation (JPML) ordered all federally filed Exactech lawsuits consolidated in the Eastern District of New York. Recently, the court released a joint status report indicating 571 cases are pending in or being transferred to this…
A Florida woman recently filed a new EzriCare eye drops lawsuit in the Circuit Court of the 11th Judicial Circuit in and for Miami-Dade County, Florida. She claims that after using the eye drops, she suffered catastrophic permanent injuries. She seeks compensation for her medical…
